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The phenothiazine (PTZ) tricyclic ring system is incorporated into a number of drugs 
that cover a broad spectrum of pathologies. Members of this family display a wide 




Due to the fact that PTZ is an active chromophore, the photochemical behavior of 
PTZ-containing drugs has attracted considerable attention, in connection with the 
possible photosensitizing side-effects experienced by treated patients.
5,6,7
 In this context, 
it has been described that the key photophysical parameters of PTZs can be influenced 




Transport proteins present in blood and plasma bind and carry a vast array of 
pharmaceuticals and consequently are important modulators of pharmacokinetics and 
disposition. The most abundant are serum albumins (SAs) and 1-acid glycoproteins 
(AAGs).
 11,12
 The interaction of several PTZ neuroleptics with AAGs has been 
investigated using circular dichroism and equilibrium dialysis techniques. In the case of 
human AAG (HAAG) it has been concluded that PTZ derivatives bind preferentially to 
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only one common binding site, where hydrophobic forces are mainly involved, although 
electrostatic interactions also participate.
 13,14,15
 The affinity of PTZs for HAAG has 
been employed for the development of glycoprotein-based stationary phases for the 
resolution of enantiomers by HPLC.
16,17,18 
 
Effective inclusion of PTZs within other biomimetic systems, such as - or - 
cyclodextrins (CDXs) or sodium dodecyl sulfate (SDS) micelles has also been 
observed.
 19,20,21 
With CDXs, PTZs inclusion complexes with different stoichiometries 
are formed. Moreover, encapsulation within -CDX protects human erythrocytes from 
photohemolysis induced by a number of PTZs.
22
 Enantioseparations of chiral PTZs 




Inclusion of PTZs within sodium dodecyl sulfate (SDS) micelles has been 
investigated using both absorption and fluorescence spectroscopies, looking at the 
influence of the PTZs protonation state on the interaction and at the competition 
between photoionization and triplet excited state formation. 
Cyamemazine (CMZ, 2-cyano-10-(3-dimethylamino-2-methylpropyl)phenothiazine, 
Chart 1) is a PTZ derivative, employed as neuroleptic drug, which exhibits strong 
cutaneous phototoxicity in humans.
24
 The drug is readily photooxidized upon UVA 
irradiation to 2-cyano-10-(3-dimethylamino-2-methylpropyl)phenothiazine N,S-dioxide 
(CMZ-SONO), which is in turn an effective photodynamic agent able to produce singlet 
oxygen. This photoproduct is also formed during UVA irradiation of cultured human 
fibroblasts incubated with the drug. Since CMZ is mainly localized in the lysosomes of 
human fibroblasts and keratinocytes, CMZ-SONO plays a central role in the 




The CMZ fluorescence spectrum in phosphate buffered solution (PBS, pH =7.4) 
displays a maximum at ca. 530 nm, and the fluorescence quantum yield is 0.11 at exc = 
267 nm. Laser flash photolysis (LFP) under the same conditions shows the transient 
spectrum of the triplet excited state (
3
CMZ*), with a characteristic band at ca. 420 nm, 
together with  the corresponding radical cation (CMZ
+•
) absorbing strongly in the 500 
nm region. Both species react with oxygen, although with markedly different rate 
constants (4 × 10
9













Chart 1. Chemical structures of CMZ and its photoproduct CMZ-SONO. 
 
A number of relevant processes occur in well-defined biological compartments; 
hence, the behavior of drugs within biomimetic microenvironments is an important 
issue. In this work, the photobehavior of enantiomerically pure CMZ has been 
examined within AAGs,  and -CDX, as well as SDS. The results show that 
phootoxidation is markedly retarded in SDS and AAGs, where the local hydrophobicity 
prevents CMZ photoionization.  
 
Experimental Section 
Materials and Solvents. HAAG, BAAG, -CDX, -CDX and SDS were commercially 


















purification. Solutions in PBS (0.01 M, pH = 7.4) were prepared by dissolving the 
commercial tablets in deionized water.  
 Racemic CMZ tartrate was kindly provided by Aventis (Vitry-sur-Seine, France) 
and kept in the dark at 4 ºC. The free base was obtained by liquid-liquid extraction of 
CMZ tartrate, using 1 M NaOH/CH2Cl2. The organic phase was dried with Na2SO4, 
filtered and evaporated in vacuo to afford racemic CMZ. Pure ()-CMZ and (+)-CMZ 
were isolated from the racemic mixture by HPLC (see Supporting Information, pp S2-
S7 for experimental details and NMR characterization). 
Fluorescence experiments. Solutions of ()- or (+)-CMZ in the absence and 
presence of different amounts of guests were placed in 10 × 10 mm
2
 quartz cells. The 
absorbance at the excitation wavelength (330 nm) was kept below 0.2. Experiments 
were performed at 22 °C. Emission spectra were recorded on a JASCO FP-8500 
spectrofluorometer system, provided with a monochromator in the wavelength range of 
200-850 nm. Time-resolved measurements were performed with a TimeMaster 
fluorescence lifetime spectrometer TM-2/2003 from PTI by means of the stroboscopic 
technique, which is a variation of the boxcar technique. A hydrogen/nitrogen flashlamp 
was used as excitation source.  
Laser flash photolysis measurements. Experiments were carried out with a pulsed 
Nd:YAG Laser system with 355 nm as excitation wavelength, 0.6 cm as beam diameter 
and a pulse duration of 10 ns. The energy was set at 15 mJ/pulse. The apparatus 
consisted of the pulsed laser, a xenon lamp, a monochromator, and a photomultiplier. 
Samples of ()- or (+)-CMZ in the absence and presence of different amounts of guests 
were placed in 10 mm × 10 mm quartz cells. The absorbance at the excitation 
wavelength was kept at 0.2. Experiments were performed at 22 °C. In general, samples 
received 2 pulses for all of the kinetic measurements. This light dose did not result in 
5 
 
any detectable decomposition of the sample, as revealed by UV-Vis absorption prior to 
and after photolysis.  
Steady-state irradiations. Solutions of ()- or (+)-CMZ 6  10
-5
 M in PBS/air were 
placed into quartz cells and irradiated at different times with monochromatic light from 
a 150W Xenon lamp at exc = 355 nm. The course of the reactions was followed by 
recording the changes in the emission spectra (exc = 330 nm). 
Results and Discussion 
The two enantiomers ()- and (+)-CMZ were isolated from the commercial racemic 
drug, using chromatographic (HPLC) resolution with a chiral stationary phase (Figure 
S1). As expected, the absorption spectra of both compounds in PBS were identical, and 
displayed an intense band with maximum at 270 nm and a tail reaching 400 nm (Figure 
S2). Excitation was performed at this longer-wavelength tail, to avoid interferences due 
to light absorption by the host. 
Fluorescence studies. Selective excitation of CMZ in the presence of AAGs was 
achieved at 330 nm. Fluorescence measurements were used to follow formation of 
CMZ@AAG complexes, through the observed changes in the position and intensity of 
the emission band, as well as in the decay traces. The results obtained for ()-CMZ are 
shown in Figure 1. In the presence of increasing amounts of AAGs, the emission band 
of ()-CMZ (initially peaking at 525 nm in PBS), underwent a progressive enhancement 
with a concomitant hypsochromic shift. At 1:2 drug/HAAG molar ratio (Figure 1A), the 
maximum was ca. 30 nm blue-shifted, and the quantum yield (F) increased from 0.064 
(in PBS) up to 0.109 (Table 1). A similar behavior was observed in the presence of the 
bovine protein BAAG (Figure 1B). This indicated efficient encapsulation of CMZ 
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within both AAGs. Accordingly, the fluorescence lifetimes (F) were higher for 












Figure 1. Fluorescence spectra of (-CMZ (6 × 10
-5
 M, λexc = 330 nm, PBS/air) in the 
presence of increasing amounts of A: HAAG (0 to 3 eq.), B: BAAG (0 to 2 eq.), C: -
CDX (0 to 200 eq.), D: SDS (0 to 1.2 × 10
-2
 M). The corresponding data for (-CMZ 
are presented in Figure S4 of SI. 
 
As alternative anisotropic media, cyclodextrins (-CDX and -CDX) and anionic 
micelles (SDS) were selected to investigate the emission behavior of encapsulated 
CMZ. In general, as mentioned above for AAGs, inclusion of (-CMZ within these 
biomimetic michroheterogeneous systems was associated with a significant blue-shift in 
the emission maxima and a marked enhancement of the fluorescence intensities (Figures 
1C, D and S3). A parallel increase in the values of the related photophysical parameters 
(F, F) was observed (Table 1).  
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Table 1. Fluorescence data for ()-CMZ in different media. 
 
 
Steady-state photochemistry. After investigating the inclusion of CMZ within the 
different hosts, the entrapped drug was irradiated under air with monochromatic light 
(irr = 355 nm). The course of the reaction was monitored by recording the fluorescence 
changes of the photomixtures (exc = 330 nm) at increasing exposure times. Formation 
of the known photoxidation product (CMZ-SONO, Chart 1) was assessed by the 
appearance of a new emission band at shorter wavelengths (max = 420 nm). Figures 
2A-D show the results obtained for ()-CMZ. Interestingly, in the presence of HAAG 
(Figure 2B) and BAAG (Figure S5A in SI) the reaction was clearly slower than in bulk 
PBS (Figure 2A). The protective effect of - (Figure 2C) and -CDX (Figure S5B in 
SI), although detectable, was less marked. The lowest photoreactivity was found inside 









) Es (kcal/mol) 
None 525 0.064 5.56 1.15 67.4 
HAAG
a 482-505 0.109 6.68 1.63 67.6 
BAAG
b 483-508 0.118 7.93 1.49 66.8 
-CDX
c 486-512 0.116 7.58 1.53 67.3 
-CDX
c 508-522 0.085 6.79 1.25 67.1 
SDS
c 496-518 0.117 8.76 1.33 66.2 




















Figure 2. Fluorescence spectra obtained after 355 nm irradiation of ()-CMZ (6 × 10
-5
 
M, λexc = 330 nm, PBS/air, 0 to 20 min) in different media. A: No host. B: CMZ/HAAG 
1:3 molar ratio. C: CMZ/-CDX 1:200 molar ratio. D: CMZ/SDS 1:200 molar ratio. 
The corresponding data for ()-CMZ are presented in Figure S6 of the SI. 
 
The progress of the reaction at different irradiation times is represented in Figure 
3. In all the microheterogeous media the process was much slower than in aqueous 








Figure 3. Photooxidation of ()-CMZ in different media. 
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 Laser flash photolysis studies. Transient absorption spectroscopy was employed 
to investigate the involvement of short-lived species in the formation of the 
photoproduct. Thus, LFP of ()-CMZ (exc = 355 nm, PBS/air) was performed in the 
different media. In PBS, absorption bands at 320 nm (
3
CMZ*) as well as at 290 nm 
(CMZ
+•
) were observed. In the 400-550 nm region, the spectra of both species overlap. 
Remarkably, upon addition of sufficient HAAG or BAAG, the contribution of CMZ
+• 
became nearly negligible in the 250-350 region, where 
3
CMZ* dominated the spectra 
(Figure 4A). In aerated atmosphere the intraprotein triplet lifetimes were considerably 
longer than in solution (Figure 4B). This effect was also observed in CDXs, although to 








Figure 4. Laser flash photolysis of (-CMZ (exc = 355 nm, PBS/air) alone and in the 
presence of two equivalents of AAGs. A: transient absorption obtained 0.5 s after the 
laser pulse. B: Decay traces monitored at  = 320 nm for ()-CMZ in the absence or 
presence of different guests. The corresponding data for ()-CMZ are presented in 
Figure S7 of the SI. 
 
 To investigate the protection provided by the different microenvironments, the 
triplet lifetimes were determined in the presence of increasing concentrations of oxygen. 
In all microheterogeneous systems, quenching by oxygen was slower than in 






); the effect was more remarkable inside 






























































However, the fact that the highest protection from photooxidation to CMZ-SONO was 
achieved inside SDS micelles (see above), where triplet quenching by oxygen was only 






) does not support a reaction pathway involving 
3
CMZ* as the key intermediate. This is in good agreement with the assumption that 




 As a matter of fact, 
photoionization does occur in PBS solution (see above), whereas it is nearly negligible 
in SDS and AAGs. 
 
Conclusions 
 The photooxidation of cyamemazine occurs through photoionization and subsequent 
trapping of the resulting radical cation by oxygen, eventually leading to the 
corresponding sulfoxide. This reaction is extremely sensitive to the medium and 
constitutes an appropriate probe for localization of the drug within a variety of 
microenvironments. The encapsulation process can be followed by fluorescence 
spectroscopy, through a clear hypsochromic shift, together with significantly enhanced 
quantum yields and lifetimes. Laser flash photolysis also reveals diagnostically 
important changes associated with encapsulation, specifically more selective generation 
of the triplet excited state, which turns out to be much longer-lived. Interestingly, as 
anticipated from the lipophilic nature of the employed microenvironments, 
photoionization to afford the radical cation is disfavored. Upon steady-state irradiation, 
formation of the sulfoxide can be easily monitored by fluorescence spectroscopy, by the 
progressive appearance of a characteristic emission band at shorter wavelengths. A good 
correlation is observed between the photophysical properties and the photochemical 
reactivity. Thus, the slowest photooxidation rate corresponds to cyamemazine in SDS 
micelles and 1-acid glycloproteins, where the drug is located in a more hydrophobic 
11 
 
domain, hardly accessible from the aqueous medium, and photoionization is nearly 
negligible. 
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